[1] 廖艳婷,孙爱农,李乔.核酸检测技术在中山地区血液筛查中的应用[J].检验医学与临床,2020,17(15):2113-2115. [2] 疾病预防控制局.2019年全国法定传染病疫情概况[EB/OL].(2020-04-20).http://www.nhc.gov.cn/jkj/s3578/202004/b1519e1bc1a944fc8ec176db600f68d1.shtml. [3] ZHANG Q,QI W Q,WANG X,et al.Epidemiology of hepatitis B and hepatitis C infections and benefits of programs for hepatitis prevention in northeastern China:a cross-sectional study[J].Clin Infect Dis,2016,62(3):305-312. [4] CHAWLA A,MURPHY G,DONNELLY C,et al.Huma n immunodeficiency virus (HIV) antibody avidity testing to identify recent infection in newly diagnosed HIV type 1 (HIV-1)-seropositive persons infected with diverse HIV-1 subtypes[J].J Clin Microbiol,2007,45(2):415-420. [5] BES M,VARGAS V,PIRON M,et al.T cell responses and viral variability in blood donation candidates with occult hepatitis B infection[J].J Hepatol,2012,56(4):765-774. [6] ZHENG X,WEINBERGER K M,GEHRKE R,et al.Mutant hepatitis B virus surface antigens (HBsAg) are immunogenic but may have a changed specificity[J].Virology,2004,329(2):454-464. [7] JAMSHIDI S,BOKHARAEI-SALIM F,ESGHAEI M,et al.Occult HCV and occult HBV coinfection in Iranian human immunodeficiency virus-infected individuals[J].J Med Virol,2020,92(12):3354-3364. [8] LI L,LI K Y,YAN K,et al.The history and challenges of blood donor screening in China[J].Transfus Med Rev,2017,31(2):89-93. [9] 蒋祺.酶联免疫吸附试验、核酸扩增技术检测在无偿献血者血液筛查中的应用[J].临床医学,2020,40(7):82-84. [10] TENG F,GUO L,CUI T T,et al.CDetection:CRISPR-Cas12b-based DNA detection with sub-attomolar sensitivity and single-base specificity[J].Genome Biol,2019,20(1):1-7. [11] YANG M Z,ZHANG W,YANG J C,et al.Skiving stacked sheets of paper into test paper for rapid and multiplexed assay[J].Sci Adv,2017,3(12):eaao4862. [12] TESS V CLENDENEN,JUSTIN RENDLEMAN,WENZHEN G E,et al.Genotyping of Single Nucleotide Polymorphisms in DNA Isolated from Serum Using Sequenom MassARRAY Technology[J].Plos One 2015,10(8):e0135943. [13] SINGH A,SOLANKI A,CHAUDHARY R.Impact of grey zone sample testing by enzyme-linked immunosorbent assay in enhancing blood safety:Experience at a tertiary care hospital in North India[J].Asian J Transfus Sci,2016,10(1):71. [14] SAYAN M,MERIÇM,MUTLU B,et al.Low positive anti-HCV microparticle enzyme immunoassay results:do they predict hepatitis C virus infection?[J].Mikrobiyoloji Bülteni,2006,40(1/2):81-84. [15] 赵艳梅,李艳,史志旭,等.无偿献血者标本血清学和核酸检测情况分析[J].临床血液学杂志,2019,32(8):604-608. [16] 黄飚,唐炜,金坚.免疫分析中的干扰物及其排除[J].标记免疫分析与临床,2004,11(3):177-179. [17] BOLSTAD N,WARREN D J,NUSTAD K.Heterophilic antibody interference in immunometric assays[J].Best Pract Res Clin Endocrinol Metab,2013,27(5):647-661. [18] RUJIPAT WASITTHANKASEM,PREEYAPORN VICHAIWATTANA,CHOMPOONUT AUPHIMAI,et al.HCV core antigen is an alternative marker to HCV RNA for evaluating active HCV infection:implications for improved diagnostic option in an era of affordable DAAs[J].PeerJ,2017,5:e4008. [19] MANCUSO M E,LINARI S,SANTAGOSTINO E,et al.High rate of sustained virological response with direct-acting antivirals in haemophiliacs with HCV infection:a multicenter study[J].Liver Int,2020,40(5):1062-1068. |